Matthew Vesely

Has grant

Assistant Professor

Yale University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matthew Vesely is an Assistant Professor at Yale School of Medicine, located in the United States. His research primarily focuses on inflammatory skin diseases, immunology, and cancer, as highlighted by his recent publications on topics such as immune checkpoint molecules and spatial transcriptomics. His work explores the interplay between immune responses and skin conditions, contributing to advancements in both clinical understanding and therapeutic approaches.

Recent Grants

Grant: Close

Determining the Immune Inhibitory Landscape in Melanoma

Open Date: 2021-03-01

Close Date: 2022-02-28

Grant: Close

Determining the Immune Inhibitory Landscape in Melanoma

Open Date: 2019-09-01

Close Date: 2021-02-28

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Xue Han

Assistant Professor

Ohio State University

UNITED STATES

View details

Aaron Newman

Assistant Professor

Stanford University

UNITED STATES

View details

Yuwen Zhu

associate professor

University of Colorado School of Medicine

UNITED STATES

View details

Christine Ko

Professor

Yale University

UNITED STATES

View details

Nicole Joller

Professor for Immunology

University of Zurich

SWITZERLAND

View details

Christina Cho

Assistant Professor

The University of Iowa

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matthew Vesely

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

PD-1H (VISTA) Expression in Cutaneous Squamous Cell Carcinoma Is Correlated with T-Cell Infiltration and Activation

Spatial Transcriptomics Reveals Differential Inflammatory Pathways in Discoid Lupus Erythematosus and Lichen Planus

Spatial Transcriptomics in Inflammatory Skin Diseases Using GeoMx Digital Spatial Profiling: A Practical Guide for Applications in Dermatology

Immune Checkpoint Agonists for Inflammatory Skin Diseases

Consultation patterns in lupus erythematosus: a retrospective review of inpatient and outpatient consultations at a single institution

Subcutaneous immunoglobulin-induced eczematous dermatitis

Type 2 immunity to the rescue: enhancing antitumor immunity for skin cancer prevention

Intravenous immunoglobulin-induced eczematous dermatitis treated with dupilumab

Association of lichen planus with asthma and allergic rhinitis in the All of Us Research Program: a cross-sectional study

Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

The CD8α–PILRα interaction maintains CD8 + T cell quiescence

Cancer Immunoediting in the Era of Immuno-oncology.

Not all well-differentiated cutaneous squamous cell carcinomas are equal: Tumors with disparate biologic behavior have differences in protein expression via digital spatial profiling.

Fever, Hypotension, and a Worsening Necrotic Wound.

Resistance Mechanisms to Anti-PD Cancer Immunotherapy.

Treatment of lichen sclerosus and hypertrophic scars with dupilumab.

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

Cytokine RNA In Situ Hybridization Permits Individualized Molecular Phenotyping in Biopsies of Psoriasis and Atopic Dermatitis

A burned-out cd8<sup>+</sup> t-cell subset expands in the tumor microenvironment and curbs cancer immunotherapy

Collaborators (6)

Xue Han

Aaron Newman

Yuwen Zhu

Christine Ko

Nicole Joller

Christina Cho

Make your next move.